Our team is constantly working with other thought leaders in the industry to publish new and exciting articles focused on advancing addiction treatment and improving client outcomes. Check out some of the most recent articles and research studies our team has been a part of below:
Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With “Dopamine Homeostasis” in Reward Deficiency Syndrome (RDS)
Taylor and Francis Online
THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS
National Center for Biotechnology Information
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner
National Center for Biotechnology Information
Hypothesizing that a Pro-Dopaminergic Regulator (KB220z™ Liquid Variant) can Induce “Dopamine Homeostasis” and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence ClinMed International Library
Lyme and dopaminergic function: Hypothesizing reduced reward deficiency symptomatology by regulating dopamine transmission
Open Access Text
Genetic Addiction Risk Score (GARS): Molecular Neurogenetic Evidence for Predisposition to Reward Deficiency Syndrome (RDS)
National Center for Biotechnology Information
Invited Commentary: In a Genomic Era, Should We Promote Dopamine Homeostasis to Treat Opiate/ Opioid Abuse, Instead of Blocking Brain Dopamine Function?
KEI Journals
Pro-Dopamine Regulation (KB220Z™)” as a Long-Term Therapeutic Modality to Overcome Reduced Resting State Dopamine Tone in Opiate /Opioid Epidemic in America
Open Access Text
KB220Z a Pro-Dopamine Regulator, Balances Brain Reward Circuitry Inducing “Homeostasis.”
The Sober World
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)
Juniper Publishers
Invited Commentary: In a Genomic Era, Should We Promote Dopamine Homeostasis to Treat Opiate/ Opioid Abuse, Instead of Blocking Brain Dopamine Function?
KEI Journals
A 21ST CENTURY PERSPECTIVE ON DEPRESSION, REWARD GENES, AND DNA POLYMORPHIC TARGETED NUTRIGENOMIC RESOLUTION
Pro-Dopamine Regulator – (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS).
Genetic farming of the Opiate/Opioid epidemic in Native Americans: Is Reward Deficiency the Culprit?
Mortality Risk During and After Opioid Substitution Treatment: Systematic Review and Meta-Analysis of Cohort Studies
“Pro-dopamine regulation (KB220Z™)” as a long-term therapeutic modality to overcome reduced resting state dopamine tone in opiate/opioid epidemic in America.
We are faced with a worldwide opiate/opioid epidemic that is devastating. According to the Centers for Disease Control and Prevention (CDC), at least 127 people, young and old, are dying every day in America due to narcotic overdose.
The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis.
